Urology Times staff

“[We] found that women were spending on average, nearly $35 a week on incontinence products in the highest symptom severity, which is a huge financial burden,” says Elisabeth M. Sebesta, MD.

“I’ve been using it my practice and also based on the literature, it seems like it is a relatively safe extract with little to no change in sexual function…and no obvious contraindications,” says Bilal Chughtai, MD.

Sacral neuromodulation administered through an implantable neurostimulator has shown promise as a therapy for patients with bladder and bowel dysfunction.

Chughtai was part of an international panel of leading urologists from North America and Europe who published the consensus paper, “Rethinking the Role of Saw Palmetto Extract for Men with Lower Urinary Tract Symptoms in North America."

Researchers examined geographic trends of private equity acquisitions of physician offices specializing in dermatology, gastroenterology, ophthalmology, obstetrics/gynecology (OB/GYN), orthopedics, and urology.

Axonics F15, a recharge-free sacral neuromodulation implantable neurostimulator for the treatment of patients with bladder and bowel dysfunction, was approved by the FDA earlier this year.

I think we need to really carefully listen to and pay attention to our APPs’ needs,” says Amanda C. North, MD.

The approval is based on findings from the phase 3 ARASENS trial.

Pramit Khetrapal, MD, discusses the abstract, “Results of the intracorporeal robotic vs open cystectomy multi-centre randomised trial,” which he presented at the 2022 AUA Annual Meeting.

Kyzatrex is an oral testosterone replacement therapy for the treatment of adult males with conditions associated with hypogonadism.

“We saw that with each additional enrichment feature the odds of finding a germline mutation would double,” says Alexis Rompré-Brodeur, MD.

“Coordination between urology and radiation oncology, if urology is placing the device, is really critical,” says Jonathan E. Shoag, MD.

“With an increase in medical and surgical therapies in younger individuals, health care providers must discuss fertility preservation options prior to affirmation therapy,” says Niki Parikh, MD, MBA, MSBA.

“The open operation is obviously done using a single incision that is quite big,” says Khetrapal.

“I think there is still a burden on women more than on men to manage everything, all at once simultaneously. And that leads to burnout, because you're constantly feeling pulled in multiple directions,” says Amanda C. North, MD.

“UGN-102 may offer a patient-centered therapeutic approach, more patient centered than standard treatments like surgery,” says Angela M. Stover, PhD.

“Healthy Now is really committed to making access to care available to all men,” says Mohit Khera, MD, MBA, MPH.

“Each patient is different, and some patients are more challenging than others in terms of placement,” says Jonathan E. Shoag, MD.

Patients in the CheckMate-914 trial had received radical or partial nephrectomy and were at moderate or high risk of relapse.

“Twenty-five percent of advanced practice providers more or less, experienced burnout, which I think is a lot higher than we would have expected,” says Amanda C. North, MD.

The novel PET imaging agent 68GA-EMP-100 PET measures c-MET expression in renal cell carcinoma.

“What we did find is that UGN-102 did not cause decrements in patient-reported urinary symptoms, bloating, flatulence, or malaise at the primary trial end point of 3 months,” says Angela M. Stover, PhD.

In this interview, Nitya E. Abraham, MD, discusses innovations in vesicovaginal fistula repair.

“We wanted to revisit the current main indications for germline testing,” says Alexis Rompré-Brodeur, MD.

“Almost half of the participating urologists did not agree that the televisits were as satisfactory as face-to-face visits,” says Nathan Feiertag.

"I would argue most people perform complicated vesicovaginal fistula repairs that can't be reached vaginally using a robotic abdominal approach," says Nitya E. Abraham, MD.

“These are men who are suffering in silence. Many of them are too embarrassed to ever discuss their sexual health problems,” says Mohit Khera, MD, MBA, MPH.

In this interview, David Joseph, MD, discusses piloting changes to the American Board of Urology Lifelong Learning Program and how they will help diplomates stay current without requiring as much time away from their families and practices.

“We were surprised that only 43% of individuals believed fertility preservation to be important, but this could be due to the relatively low age of our respondents, with the majority being between 18 and 39 years old,” says Niki Parikh, MD, MBA, MSBA.

In this interview, Catherine Ann Matthews, MD, FACS, FACOG, discusses the resurgence of single-incision slings and outlines a clinical trial of slings that she is currently leading.